Ductal carcinoma in situ: Trends in geographic, temporal, and demographic patterns of care and survival

Breast Journal

Volumn 12, Issue 1, 2006, Pages 20-27

  Joslyn, Sue A ^a  

^a UNIVERSITY OF NORTHERN IOWA   (United States)

Author keywords

Breast cancer; Ductal carcinoma in situ; Patterns of care; Survival

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; DUCTAL CARCINOMA IN SITU; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PARTIAL MASTECTOMY; PATIENT CARE; PROGNOSIS; PUBLIC HEALTH SERVICE; RACE; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; DEMOGRAPHY; DISEASE-FREE SURVIVAL; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES; WOMEN'S HEALTH SERVICES;

EID: 33644889095     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2006.00182.x     Document Type: Article

References (48)

1. Blackman DK Bennett EM Miller DS Trends in self-reported use of mammograms (1989-1997) and Papanicolaou tests (1991-1997) - Behavioral Risk Factor Surveillance System MMWR CDC Surveill Summ 1999 48 1 22
2. Wun LM Feuer EJ Miller BA Are increases in mammographic screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 1995 6 135 44
3. Fisher B Costantino J Redmond C et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer N Engl J Med 1993 328 1581 86
4. Fisher B Dignam J Wolmark N Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17 J Clin Oncol 1998 16 441 52
5. Julien JP Bijker N Fentiman IS et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group Lancet 2000 355 528 33
6. Boyages J Delaney G Taylor R Predictors of local recurrence after treatment of ductal carcinoma in situ Cancer 1999 85 616 28
7. Schwartz GF Consensus Conference on the Classification of Ductal Carcinoma in Situ. The current treatment of ductal carcinoma in situ Breast J 2001 7 308 10
8. Morabia A Flandre P Misclassification bias related to definition of menopausal status in case-control studies of breast cancer Int J Epidemiol 1992 21 222 27
9. Wittliff JL Steroid hormone receptors in breast cancer Cancer 1984 53 630 43
10. Hawkins RA Roberts MM Forrest APM Oestrogen receptors and breast cancer: current status Br J Surg 1980 67 153 69
11. Kaplan EL Meier P Non-parametric estimates from incomplete observations J Am Stat Assoc 1958 53 457 81
12. Cox DR Regression models and life tables J Stat Soc B 1972 34 187 220
13. Wu X Chen VW Ruiz B et al. Patterns of treatment for ductal carcinoma in situ of the breast in Louisiana, 1988-1999 J La State Med Soc 2003 155 206 13
14. Innos K Horn-Ross PL Recent trends and racial ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women Cancer 2003 97 1099 106
15. Winchester DJ Menck HR Winchester DP National treatment trends for ductal carcinoma in situ of the breast Arch Surg 1997 132 660 65
16. Barchielli A Paci E Giorgi D Recent trends of in situ carcinoma of the breast and mammographic screening in the Florence area, Italy Cancer Causes Control 1999 10 313 17
17. Hislop TG Coldman AJ Olivotto IA D'yachkova Y Speers C Local and regional therapy for women with breast cancer in British Columbia Breast J 2003 9 192 99
18. Verkooijen HM Fioretta G deWolf C et al. Management of women with ductal carcinoma in situ of the breast: a population based study Ann Oncol 2002 13 1236 45
19. Kotwall C Brinker C Covington D et al. Local and national trends over a decade in the surgical treatment of ductal carcinoma in situ Am J Surg 2003 186 723 29
20. Baxter NN Virnig BA Durham SB Tuttle TM Trends in the treatment of ductal carcinoma in situ of the breast J Natl Cancer Inst 2004 96 443 48
21. Joslyn SA Racial differences in treatment and survival from early stage breast carcinoma Cancer 2002 95 1759 66
22. Wojcik BE Spinks MK Optenberg SA Breast carcinoma survival analyses for African American and white women in an equal-access health care system Cancer 1998 82 1310 18
23. Lindau ST Tomori C McCarville MA Bennett CL Improving rates of cervical cancer screening and Pap smear follow-up for low-income women with limited health literacy Cancer Invest 2001 19 316 23
24. Kleeberger CA Phair JP Strathdee SA Detels R Kingsly L Jacobson LP Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study J Acquir Immune Defic Syndr 2001 26 82 92
25. Howard DL Penchansky R Brown MB Disaggregating the effects of race on breast cancer survival Fam Med 1998 30 228 35
26. Cooper WO Hickson GB Corticosteroid prescription filling for children covered by Medicaid following an emergency department visit or hospitalization for asthma Arch Pediatr Adolesc Med 2001 155 1111 15
27. Li BDL Brown WA Ampil FL Burton GV Yu H McDonald JC Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conserving therapy Ann Surg 2000 231 883 89
28. Smith RG Landry JC Hughes LL et al. Conservative treatment of early stage breast cancer in a medically indigent population J Natl Med Assoc 1995 87 500 504
29. Queen S Pappas G Hadden W Fisher G The widening gap between socioeconomic status and mortality Stat Bull Metrop Insur Co 1994 75 31 35
30. Sorlie P Rogot E Anderson R Johnson NJ Backlund E Black-white mortality differences by family income Lancet 1992 340 346 50
31. Sterling T Rosenbaum W Weinkam J Income, race, and mortality J Natl Med Assoc 1993 85 906 11
32. Breen N Wesley MN Merril RM Johnson K The relationship of socioeconomic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute's black-white cancer survival study Ethn Dis 1999 9 111 25
33. Peterson LA Wright SM Peterson ED Daly J Impact of race on cardiac care and outcomes in veterans with acute myocardial infarction Med Care 2002 40 suppl 1 86 96
34. Collins TC Johnson M Henderson W Khuri SF Daley J Lower extremity nontraumatic amputation among veterans with peripheral arterial disease: is race an independent factor? Med Care 2002 40 suppl 1 106 16
35. Dominitz JA Maynard C Billingsly KG Boyko EJ Race, treatment, and survival of veterans with cancer of the distal esophagus and gastric cardia Med Care 2002 40 suppl 1 14 26
36. Wenneker MB Epstein AM Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts JAMA 1989 261 253 57
37. van Ryn M Research on the provider contribution to race/ethnicity disparities in medical care Med Care 2002 40 suppl 1 140 51
38. Dignam JJ Colangelo L Tian W et al. Outcomes among African Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project J Natl Cancer Inst 1999 91 1933 40
39. Council on Ethical and Judicial Affairs. Black-white disparities in health care JAMA 1990 263 2344 46
40. Harris DR Andrews R Elixhauser A Racial and gender differences in use of procedures in black and white hospitalized adults Ethn Dis 1997 7 91 105
41. Choi WS Parker BA Pierce JP Greenberg ER Regional differences in the incidence and treatment of carcinoma in situ of the breast Cancer Epidemiol Biomarkers Prev 1996 5 317 20
42. Goldstein NS Vicini FA Kestin LL et al. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age Cancer 2000 88 2553 60
43. Bijker N Peterse JL Duchateau L et al. Risk factors for recurrence and metastasis after breast-conserving treatment for ductal carcinoma in situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853 J Clin Oncol 2001 19 2263 71
44. Fisher B Dignam J Wolmark N et al. Tamoxifen in trials of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 1999 353 1993 2000
45. Solin LJ Fourquet A Vicini FA et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status Int J Radiat Oncol Biol Phys 2001 50 991 1002
46. Van Zee KJ Liberman L Samli B et al. Long term follow-up of women diagnosed with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age Cancer 1999 86 1757 67
47. Solin LJ Fourquet A Vicini FA et al. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast Cancer 2001 91 1090 97
48. Vicini FA Recht A Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast: a critical review of the literature J Clin Oncol 2002 20 2736 44